A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS

NCT00000644 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

NIH

Sponsor class

Conditions

Mycobacterium Avium-intracellulare Infection
HIV Infections

Interventions

DRUG: Clarithromycin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]